Clinical Trial

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2020-07-29; most recent amendment 2025-10-16.
Status change: Recruiting → Active, Not Recruiting 2024-06-28
Status change: Not Yet Recruiting → Recruiting 2020-08-25
Trial Details
NCT Number NCT04496518
Lead Sponsor Medtronic
Conditions Ventricular Tachycardia
Enrollment 2,200 participants
Start Date 2020-08-01
Primary Completion 2024-11-06 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-20